FindTrial
Sign In

CT perfusion application of rectal carcinoma recurrence

CT perfusion application of rectal carcinoma recurrence

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-11001214
Enrollment
Unknown
Registered
2011-03-03
Start date
2009-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal carcinoma.

Interventions

Gold Standard:
Index test:

Sponsors

First Hospital of Peking University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The rectal carcinoma patients who have received Mile's operation find solid mass before the sacrum.

Exclusion criteria

Exclusion criteria: 1. Pregnant or breast feeding women; 2. Allergic to non-ionic iodine contrast medium; 3. With hyperthyroidism; 4. With acute or chronic renal dysfunction; (GFR<30ml/min/1.73m2); 5. With serious organ failure; 6. With concomitant diseases who may not complete the examination.

Design outcomes

Primary

MeasureTime frame
blood flow;permeability surface;mean transit time;blood volume;X ray dose;—

Countries

China

Contacts

Public ContactXiaoying WANG
cjr.wangxiaoying@vip.163.com+86 10 83572097

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026